Nano Imrad Technology (NIT), an innovative medical research and development company, is pleased to announce the availability ...

Legislation has been proposed in Congress to bring diagnostic tests under a single regulatory framework, but if it doesn’t pass, the FDA has authority to regulate lab-developed tests, the groups said.

After failing to bring its surgical robot to market and getting kicked off the Nasdaq, Titan is now marketing its intellectual property.

The acquisition is aimed at strengthening Getinge’s position in the fast-growing area of custom single-use solutions for bioprocessing applications.

Potential applications of the technology include the treatment of painful bladder syndrome, a condition that is currently managed with multiple injections.

Beta Bionics’ device, aimed at people with Type 1 diabetes, has eliminated most of the data entry required by competitors.

The “Mad Money” show host said shares of medical device companies stand to benefit from pent-up demand for surgeries postponed during the COVID-19 pandemic.

The Federal Trade Commission said Boston Scientific took the action in response to investigations by its staff and overseas enforcement partners.

A study found the test is a better predictor of the risk of developing preeclampsia with severe features than standard clinical measures.

The tubeless, disposable insulin patch made by EOFlow will be integrated into the newly launched MiniMed 780G system, Medtronic said.

John Mazzola will oversee operations as Vicarious prepares to seek FDA approval for a robotic surgery system that would take on Intuitive Surgical’s market-leading da Vinci robot.

The staff reductions at Abbott’s Westbrook manufacturing plant come as the company forecasts decreasing demand for the tests in 2023.